ARTICLE | Company News
Medarex, Scil Biomedicals deal
January 10, 2000 8:00 AM UTC
Scil received development and marketing rights in Europe and the Near East to MEDX's MDX-RA, a monoclonal antibody linked to ricin in Phase III testing to prevent secondary cataracts, and MDX-210, an ...